Zevra Therapeutics, Inc. (ZVRA) ownership: Woodline Partners LP 10% · institutions 77% · index and ETF funds 5% (13F 2026-06-30). Insider activity, 90 days: 3 sales, 0 open-market buys. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| BlackRock | 5108871.00 | $73.26M | 8.6% | 2026-06-30 |
| FMR (Fidelity) | 4915717.00 | $70.49M | 8.3% | 2026-06-30 |
| Woodline Partners LP | 4785771.00 | $68.63M | 8.1% | 2026-06-30 |
| Vanguard | 3600473.00 | $51.63M | 6.1% | 2026-06-30 |
| Nantahala Capital Management, LLC | 1797476.00 | $25.78M | 3.0% | 2026-06-30 |
| State Street | 1681999.00 | $24.12M | 2.8% | 2026-06-30 |
| Geode Capital Management | 1540936.00 | $22.10M | 2.6% | 2026-06-30 |
| D. E. Shaw | 1306949.00 | $18.74M | 2.2% | 2026-06-30 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-14 | |
| Sell | null | 2026-08-10 | |
| Sell | null | 2026-08-10 | |
| Sell | null | 2026-08-10 | |
| Sell | null | 2026-06-21 | |
| Sell | null | 2026-06-21 | |
| Sell | null | 2026-06-21 | |
| Sell | null | 2026-06-04 |
Back to ZVRA overview · ZVRA earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.